Inhibitory effects on cytochrome P450 enzymes of pentamidine and its amidoxime pro-drug

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 1, 2008, Pages 61-65

  Bürenheide, Anja ^a   Kunze, Thomas ^a   Clement, Bernd ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; FLUVOXAMINE; ISOENZYME; KETOCONAZOLE; N,N' DIHYDROXYPENTAMIDINE; PENTAMIDINE; PENTAMIDINE DERIVATIVE; PRODRUG; QUINIDINE; SULFAPHENAZOLE; TRANYLCYPROMINE;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME INHIBITION; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER MICROSOME; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HUMANS; ISOENZYMES; MICROSOMES, LIVER; PENTAMIDINE; PRODRUGS;

PNEUMOCYSTIS;

EID: 45749137112     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00236.x     Document Type: Article

References (43)

1. Lourie EM, Yorke W. Studies in chemotherapy. XXI. The trypanocidal action of certain aromatic diamidines. Ann Trop Med Parasitol 1939 33 : 289 304.
2. Das BP, Boykin DW. Synthesis and antiprotozoal activity of 2,5-bis(4-guanylphenyl)furans. J Med Chem 1977 20 : 531 6.
3. Clement B, Raether W. Amidoximes of pentamidine: synthesis, trypanocidal and leishmanicidal activity. Arzneimittelforschung 1985 35 : 1009 14.
4. Bell CA, Hall JE, Kyle DE, Grogl M, Ohemeng KA, Allen MA et al. Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis. Antimicrob Agents Chemother 1990 34 : 1381 6.
5. Lindsay DS, Blagburn BL, Hall JE, Tidwell RR. Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures. Antimicrob Agents Chemother 1991 35 : 1914 6.
6. Pesanti EL, Cox C. Metabolic and synthetic activities of Pneumocystis carinii in vitro. Infect Immun 1981 34 : 908 14.
7. Pifer LL, Pifer DD, Woods DR. Biological profile and response to anti-pneumocystis agents of Pneumocystis carinii in cell culture. Antimicrob Agents Chemother 1983 24 : 674 8.
8. Berger BJ, Lombardy RJ, Marbury GD, Bell CA, Dykstra CC, Hall JE et al. Metabolic N-hydroxylation of pentamidine in vitro. Antimicrob Agents Chemother 1990a 34 : 1678 84.
9. Berger BJ, Reddy VV, Le ST, Lombardy RJ, Hall JE, Tidwell RR. Hydroxylation of pentamidine by rat liver microsomes. J Pharmacol Exp Ther 1991 256 : 883 9.
10. Berger BJ, Naiman NA, Hall JE, Peggins J, Brewer TG, Tidwell RR. Primary and secondary metabolism of pentamidine by rats. Antimicrob Agents Chemother 1992 36 : 1825 31.
11. 14C-pentamidine and identification of metabolites in urine using liquid chromatography-tandem mass spectrometry. Pharmacol Toxicol 1995 77 : 114 20.
12. Clement B, Jung F. N-hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Possible relationship to the biological oxidation of arginine to NG-hydroxyarginine, citrulline, and nitric oxide. Drug Metab Dispos 1994 22 : 486 97.
13. Clement B, Bürenheide A, Rieckert W, Schwarz J. Diacetydiamidoximeester of pentamidine, a prodrug for treatment of protozoal diseases: synthesis, in vitro and in vivo biotransformation. Chem Med Chem 2006 1 : 1260 7.
14. Clement B, Immel M, Terlinden R, Wingen FJ. Reduction of amidoxime derivatives to pentamidine in vivo. Arch Pharm (Weinheim) 1992 325 : 61 62.
15. Ettmayer P, Amidon GL, Clement B, Testa B. Lessons learned from marketed and investigational prodrugs. J Med Chem 2004 47 : 2393 2404.
16. Clement B. Methoden zur Behandlung und Prophylaxe der Pneumocystis carinii Pneumonie (PCP) und anderen Erkrankungen sowie Verbindungen und Formulierungen zum Gebrauch bei besagten Methoden. German patent, P 4321444.4, PCT/DE 94/00756(1994); USA (5, 786, 383;28/6/1998); Europe (0708640, 16/9/1998).
17. Clement B, u.a. Verbesserung der Bioverfügbarkeit von Wirkstoffen mit Amidin-funktion in Arzneimitteln, Anmeldetag 21.07.2006, DE 10 2006 034 256.9.
18. Kadlubar FF, Ziegler DM. Properties of a NADH-dependent N-hydroxy amine reductase isolated from pig liver microsomes. Arch Biochem Biophys 1974 162 : 83 92.
19. 2-insensitive NADH-benzamidoxime reductase. J Biol Chem 1997 272 : 19615 20.
20. Andersson S, Hofmann Y, Nordling A, Li XQ, Nivelius S, Andersson TB et al. Characterization and partial purification of the rat and human enzyme systems active in the reduction of N-hydroxymelagatran and benzamidoxime. Drug Metab Dispos 2005 33 : 570 8.
21. Havemeyer A, Bittner F, Wollers S, Mendel R, Kunze T, Clement B. Identification of the missing component in the mitochondrial benzamidoxime prodrug converting system as a novel molybdenum enzyme. J Biol Chem 2006 281 : 34796 802.
22. Clement B, Demesmaeker M, Linne S. Microsomal catalyzed N-hydroxylation of guanabenz and reduction of the N-hydroxylated metabolite: characterization of the two reactions and genotoxic potential of guanoxabenz. Chem Res Toxicol 1996 9 : 682 8.
23. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985 150 : 76 85.
24. Omura T, Sato R. The carbon monoxide binding pigment of liver microsomes. J Biol Chem 1964 239 : 2370 8.
25. Zebothsen I, Kunze T, Clement B. Inhibitory effects of cytostatically active 6-aminobenzo[c]phenanthridines on cytochrome P450 enzymes in human hepatic microsomes. Basic Clin Pharmacol Toxicol 2006 99 : 37 43.
26. Busby WF, Ackermann JM, Crespi CL. Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P450. Drug Metab Dispos 1999 27 : 246 9.
27. Chauret N, Gauthier A, Nicoll-Griffith DA. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug Metab Dispos 1998 26 : 1 4.
28. Hickman D, Wang JP, Wang Y, Unadkat JD. Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Drug Metab Dispos 1998 26 : 207 15.
29. Bapiro TE, Egnell A, Hasler JA, Masimirembra CM. Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos 2001 29 : 30 5.
30. White N. Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci 1999 354 : 739 49.
31. http://www.who.int/topics/leishmaniasis/en/ May 2000.
32. Watson J. Pneumocystis carinii: where are we now? J HIV Ther 2002 7 : 8 12.
33. Kremers P. Can drug-drug interactions be predicted from in vitro studies? Scientific World Journal 2002 2 : 751 66.
34. Committee for Proprietary Medicinal Products. Note for Guidance on the Investigation for Drug Interactions (CPMP/EWP/560/95). The European Agency for Evaluation of Medicinal Products, Human Medicines Evaluation Unit, London, 17 December 1997.
35. Wang RW, Newton DJ, Scheri TD, Lu AY. Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N-demethylation. Competition during catalysis. Drug Metab Dispos 1997 25 : 502 7.
36. Easterbrook J, Lu C, Sakai Y, Li AP. Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes. Drug Metab Dispos 2001 29 : 141 4.
37. Donkor IO, Huang TL, Tao B, Rattendi D, Lane S, Vargas M et al. Trypanocidal activity of conformationally restricted pentamidine congeners. J Med Chem 2003 46 : 1041 8.
38. Ismail MA, Brun R, Wenzler T, Tanious FA, Wilson WD, Boykin DW. Dicationic biphenyl benzimidazole derivates as antiprotozoal agents. Bioorg Med Chem 2004 12 : 5405 13.
39. Arafa RK, Brun R, Wenzler T, Tanious FA, Wilson WD, Stephens CE et al. Synthesis, DNA affinity, and antiprotozoal activity of fused ring dicationic compounds and their prodrugs. J Med Chem 2005 48 : 5480 8.
40. Brendle JJ, Outlaw A, Kumar A, Boykin DW, Patrick DA, Tidwell RR et al. Antileishmanial activities of several classes of aromatic dications. Antimicrob Agents Chemother 2002 46 : 797 807.
41. Waalkes TP, Makulu DR. Pharmacologic aspects of pentamidine. Natl Cancer Inst Monogr 1976 43 : 171 7.
42. Berger BJ, Hall JE, Tidwell RR. The distribution of multiple doses of pentamidine in rats. Pharmacol Toxicol 1990b 66 : 234 6.
43. 14C pentamidine following intravenous and inhalational administration in rats. Med Klin (Munich) 1990 85 (Suppl 2 236 44.